Standard Biotools Inc (LAB) — Comparison of Productivity to Peers
Standard Biotools Inc 's Productivity vs Peers Comparison
Table 1: Market Cap, Revenue per Employee, Income per Employee for the 12 Months period ended in Q3 2025
| COMPANY NAME TICKER |
MARKET CAP (Millions $) |
REVENUE / EMPLOYEE ($) in 12 months |
INCOME / EMPLOYEE ($) in 12 months |
|---|---|---|---|
|
Standard Biotools Inc
LAB |
555 | 642,366 | -634,906 |
|
Thermo Fisher Scientific Inc
TMO |
216,322 | 358,492 | 53,893 |
|
Illumina Inc
ILMN |
20,770 | 463,568 | 75,892 |
|
Agilent Technologies inc
A |
39,809 | 378,436 | 81,397 |
|
Bio rad Laboratories Inc
BIO |
8,296 | 318,507 | -84,172 |
|
Qiagen N v
QGEN |
10,162 | 330,922 | 14,412 |
|
Becton Dickinson And Company
BDX |
57,920 | 295,135 | 22,676 |
|
Olink Holding Ab publ
OLK |
3,297 | 423,653 | -79,000 |
|
Cytek Biosciences Inc
CTKB |
620 | 796,713 | -24,791 |
|
Bruker Corporation
BRKR |
6,851 | 293,935 | -2,768 |
|
Akoya Biosciences Inc
AKYA |
68 | 238,348 | -142,742 |
|
Astrotech Corp
ASTC |
7 | 43,733 | -467,900 |
|
Avantor Inc
AVTR |
7,615 | 487,052 | -6,089 |
|
Harvard Bioscience Inc
HBIO |
33 | 244,363 | -151,648 |
|
Mettler Toledo International Inc
MTD |
28,669 | 246,362 | 52,233 |
|
Nautilus Biotechnology Inc
NAUT |
234 | - | -872,417 |
|
Singular Genomics Systems Inc
OMIC |
50 | 14,032 | -454,326 |
|
Pressure Biosciences Inc
PBIO |
0 | 124,279 | -2,454,139 |
|
Quanterix Corporation
QTRX |
348 | 276,200 | -203,104 |
|
Rapid Micro Biosystems Inc
RPID |
164 | 187,258 | -104 |
|
Reflect Scientific Inc
RSCF |
4 | 37,091 | -396 |
|
Revvity Inc
RVTY |
11,603 | 244,641 | 20,651 |
|
Scientific Industries Inc
SCND |
7 | 179,062 | -128,908 |
|
Telesis Bio Inc
TBIO |
0 | 1,269,273 | -4,141,000 |
|
10x Genomics Inc
TXG |
1,940 | 507,929 | -16,863 |
|
Pacific Biosciences Of California Inc
PACB |
638 | 268,299 | -875,885 |
| SUBTOTAL | 415,423 | 338,715 | 33,623 |
What this table shows: Productivity metrics illustrate how effectively a company converts workforce and capital into value. Higher Revenue per Employee and Net Income per Employee generally reflect stronger operating efficiency and business scalability. First row shows Company's Productivity, followed by it's corporate peers. Click any company name in the table to view its complete financial analysis and comparison.
Standard Biotools Inc 's Financial Strength vs Peers Comparison
Table 2: Quick Ratio, Working Capital, Debt/Equity, Asset Turnover
| COMPANY NAME TICKER |
QUICK (Ratio) |
WORKING CAPITAL (Ratio) |
DEBT / EQUITY (Ratio) |
ASSET TURNOVER (Ratio) |
|---|---|---|---|---|
|
Standard Biotools Inc LAB |
3.00 | 5.18 | 0.00 | 0.23 |
| Thermo Fisher Scientific Inc
TMO |
0.40 | 1.71 | 0.68 | 0.44 |
| Illumina Inc
ILMN |
0.10 | 1.69 | 0.85 | 0.69 |
| Agilent Technologies inc
A |
0.76 | 2.16 | 0.56 | 0.56 |
| Bio rad Laboratories Inc
BIO |
2.99 | 5.73 | 0.18 | 0.26 |
| Qiagen N v
QGEN |
2.12 | 3.61 | 0.39 | 0.34 |
| Becton Dickinson And Company
BDX |
0.18 | 1.20 | 0.70 | 0.40 |
| Olink Holding Ab publ
OLK |
2.18 | 4.75 | - | 0.28 |
| Cytek Biosciences Inc
CTKB |
3.96 | 5.69 | 0.00 | 0.41 |
| Bruker Corporation
BRKR |
0.14 | 1.66 | 1.10 | 0.41 |
| Akoya Biosciences Inc
AKYA |
0.72 | 1.56 | 8.09 | 0.62 |
| Astrotech Corp
ASTC |
8.24 | 9.86 | - | 0.05 |
| Avantor Inc
AVTR |
0.16 | 1.13 | 0.68 | 0.54 |
| Harvard Bioscience Inc
HBIO |
0.11 | 0.81 | 1.31 | 0.95 |
| Mettler Toledo International Inc
MTD |
0.03 | 1.06 | - | 1.18 |
| Nautilus Biotechnology Inc
NAUT |
16.65 | 17.00 | - | - |
| Singular Genomics Systems Inc
OMIC |
8.30 | 9.25 | 0.05 | 0.01 |
| Pressure Biosciences Inc
PBIO |
0.00 | 0.02 | - | 0.45 |
| Quanterix Corporation
QTRX |
4.58 | 6.03 | - | 0.32 |
| Rapid Micro Biosystems Inc
RPID |
2.52 | 4.28 | 0.08 | 0.36 |
| Reflect Scientific Inc
RSCF |
2.68 | 5.10 | - | 0.65 |
| Revvity Inc
RVTY |
1.32 | 2.83 | 0.42 | 0.23 |
| Scientific Industries Inc
SCND |
- | 4.88 | - | 0.76 |
| Telesis Bio Inc
TBIO |
0.76 | 2.63 | - | 0.26 |
| 10x Genomics Inc
TXG |
3.61 | 5.11 | - | 0.67 |
| Pacific Biosciences Of California Inc
PACB |
5.26 | 6.83 | 3.72 | 0.16 |
| SUBTOTAL | 0.46 | 1.73 | 0.64 | 0.43 |
Standard Biotools Inc — Financial Strength vs Peers (Peer Comparison)
This table compares Quick Ratio, Working Capital, Debt-to-Equity, and Asset Turnover for Standard Biotools Inc and its closest competitors. Only the top peers are shown publicly to ensure fast loading and a clear overview.
| COMPANY NAME TICKER |
QUICK Ratio |
WORKING CAPITAL Ratio |
DEBT / EQUITY Ratio |
ASSET TURNOVER Ratio |
|---|---|---|---|---|
|
Standard Biotools Inc LAB |
3.00 | 5.18 | 0.00 | 0.23 |
|
Thermo Fisher Scientific Inc TMO |
0.40 | 1.71 | 0.68 | 0.44 |
|
Illumina Inc ILMN |
0.10 | 1.69 | 0.85 | 0.69 |
|
Agilent Technologies inc A |
0.76 | 2.16 | 0.56 | 0.56 |
|
Bio rad Laboratories Inc BIO |
2.99 | 5.73 | 0.18 | 0.26 |
|
Qiagen N v QGEN |
2.12 | 3.61 | 0.39 | 0.34 |
| Unlock Full Competitor List | ||||
What this table shows: Financial Strength ratios measure short-term liquidity (Quick Ratio, Working Capital), leverage (Debt/Equity), and operational utilization (Asset Turnover). These indicators highlight how well management allocates resources and maintains financial stability.
Standard Biotools Inc 's Underlying Financial Totals (Revenue, Income, Employees) vs Peers Comparison
Table 3: Revenue (TTM), Net Income (TTM), Net Margin, Employees, ending Q3 2025
| COMPANY NAME TICKER |
REVENUE (TTM) Millions $ |
NET INCOME (TTM) Millions $ |
NET MARGIN (%) |
NUMBER OF EMPLOYEES |
|---|---|---|---|---|
| Standard Biotools Inc LAB |
129.8 | -128.3 | -98.84% | 202 |
| Thermo Fisher Scientific Inc TMO |
43,736 | 6,575 | 15.03% | 122,000 |
| Illumina Inc ILMN |
4,288 | 702 | 16.37% | 9,250 |
| Agilent Technologies inc A |
6,774 | 1,457 | 21.51% | 17,900 |
| Bio rad Laboratories Inc BIO |
2,558 | -676 | -26.43% | 8,030 |
| Qiagen N v QGEN |
1,919 | 84 | 4.36% | 5,800 |
| Becton Dickinson And Company BDX |
21,840 | 1,678 | 7.68% | 74,000 |
| Olink Holding Ab publ OLK |
169 | -32 | -18.65% | 400 |
| Cytek Biosciences Inc CTKB |
202 | -6 | -3.11% | 254 |
| Bruker Corporation BRKR |
2,506 | -24 | -0.94% | 8,525 |
| Akoya Biosciences Inc AKYA |
79 | -48 | -59.89% | 333 |
| Astrotech Corp ASTC |
1 | -14 | -1069.89% | 30 |
| Avantor Inc AVTR |
6,575 | -82 | -1.25% | 13,500 |
| Harvard Bioscience Inc HBIO |
87 | -54 | -62.06% | 355 |
| Mettler Toledo International Inc MTD |
3,942 | 836 | 21.2% | 16,000 |
| Nautilus Biotechnology Inc NAUT |
- | -63 | - | 72 |
| Singular Genomics Systems Inc OMIC |
3 | -86 | -3237.88% | 190 |
| Pressure Biosciences Inc PBIO |
2 | -37 | -1974.71% | 15 |
| Quanterix Corporation QTRX |
130 | -96 | -73.54% | 471 |
| Rapid Micro Biosystems Inc RPID |
31 | 0 | -0.06% | 163 |
| Reflect Scientific Inc RSCF |
2 | 0 | -1.07% | 45 |
| Revvity Inc RVTY |
2,813 | 237 | 8.44% | 11,500 |
| Scientific Industries Inc SCND |
9 | -6 | -71.99% | 50 |
| Telesis Bio Inc TBIO |
14 | -46 | -326.25% | 11 |
| 10x Genomics Inc TXG |
639 | -21 | -3.32% | 1,259 |
| Pacific Biosciences Of California Inc PACB |
154 | -504 | -326.46% | 575 |
| SUBTOTAL | 98,474 | 9,775 | 9.93% | 290,728 |
What this table shows: These totals provide the raw financial fundamentals behind the productivity, Revenue and Income per Employee ratios above. Revenue, Net Income, and Employee counts reflect the company’s scale, profitability, and workforce size. TTM refers to trailing twelve months.
Methodology & Data Source: Market Capitalization is computed from the latest available share price (delayed up to 15 minutes, depending on exchange rules) multiplied by the company’s diluted share count as reported in its filings. Revenue and Net Income figures used to calculate Revenue per Employee and Net Income per Employee are sourced directly from quarterly and annual financial statements submitted to the U.S. Securities and Exchange Commission (SEC). Employee counts are taken from the most recent Form 10-K or 10-Q disclosure and may be updated by companies in subsequent SEC submissions. All fundamentals are processed through CSIMarket.com’s XBRL normalization pipeline, which standardizes reported values across all issuers and periods.
Data lineage: SEC Filings → XBRL Extraction → CSIMarket Normalization → Productivity Metrics.
This table is one of the productivity comparisons available for
Standard Biotools Inc . Across CSIMarket, we provide
nine related comparison tables showing how Standard Biotools Inc performs against its
Peers, including additional breakdowns visible through our main navigation bar under:
Stocks → Peers.
This page compares Standard Biotools Inc to its Peers based on Productivity (Market Cap, Revenue per Employee, and Net Income per Employee).
• For a deeper productivity comparison against its industry peers, visit
Standard Biotools Inc Productivity vs. Industry
• To review historical productivity trends for this company, including long-term changes in Revenue per Employee and Net Income per Employee, visit
Standard Biotools Inc Productivity History
Page last updated:
CSIMarket data powering this analysis is available across multiple delivery channels:
• Data Downloads (CSV / Excel)
• API & Programmatic Data Access
• Enterprise Data Licensing
• AI Training & Model Development License
• Marketplace Distribution Options
All CSIMarket datasets are designed for analytical workflows, financial modeling, academic research,
and AI/ML applications requiring normalized, reliable, and longitudinal financial time series.
To download the tables, please subscribe.